During the past decade, Clinical Investigations of Texas, LLC conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 13 clinical trials were completed, i.e. on average, 118.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Investigations of Texas, LLC" #1 sponsor was "Pfizer" with 4 trials, followed by "Iroko Pharmaceuticals, LLC" with 3 trials sponsored, "ACADIA Pharmaceuticals Inc." with 1 trials sponsored, "Centrexion Therapeutics" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Investigations of Texas, LLC" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Investigations of Texas, LLC" are "Osteoarthritis" (6 trials), "Osteoarthritis, Knee" (4 trials), "Osteoarthritis, Hip" (3 trials), "Arthritis" (2 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Clinical Investigations of Texas, LLC" in a lesser frequency.

Most popular intervention types in "Clinical Investigations of Texas, LLC" are "Drug" (15 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Diclofenac" (3 trials), "tanezumab" (2 trials), "ACP-044 Dose A" (1 trials) and "ACP-044 Dose B" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Investigations of Texas, LLC" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Investigations of Texas, LLC". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Clinical Investigations of Texas, LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Investigations of Texas, LLC, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".